Does Estimated Pulse Wave Velocity Add Prognostic Information?: MORGAM Prospective Cohort Project.


Journal

Hypertension (Dallas, Tex. : 1979)
ISSN: 1524-4563
Titre abrégé: Hypertension
Pays: United States
ID NLM: 7906255

Informations de publication

Date de publication:
06 2020
Historique:
pubmed: 11 4 2020
medline: 10 4 2021
entrez: 11 4 2020
Statut: ppublish

Résumé

The Reference Values for Arterial Stiffness Collaboration has derived an equation using age and mean blood pressure to estimated pulse wave velocity (ePWV), which predicted cardiovascular events independently of Systematic COoronary Risk Evaluation (SCORE) and Framingham Risk Score. The study aim was to investigate the independent association between ePWV and clinical outcomes in 107 599 apparently healthy subjects (53% men) aged 19 to 97 years from the MORGAM Project who were included between 1982 and 2002 in 38 cohorts from 11 countries. Using multiple Cox-regression analyses, the predictive value of ePWV was calculated adjusting for country of inclusion and either SCORE, Framingham Risk Score, or traditional cardiovascular risk factors (age, sex, smoking, systolic blood pressure, body mass index [BMI], total and high-density lipoprotein cholesterol). Cardiovascular mortality consisted of fatal stroke, fatal myocardial infarction, or coronary death, and the composite cardiovascular end point consisted of stroke, myocardial infarction, or coronary death. Model discrimination was assessed using Harrell's

Identifiants

pubmed: 32275189
doi: 10.1161/HYPERTENSIONAHA.119.14088
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1420-1428

Subventions

Organisme : Medical Research Council
ID : G0601463
Pays : United Kingdom

Auteurs

Julie K K Vishram-Nielsen (JKK)

From the Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, The Capital Region of Denmark, Copenhagen, Denmark (J.K.K.V.-N., A.L.).
Department of Cardiology, Rigshospitalet (J.K.K.V.-N.), University of Copenhagen, Denmark.

Stephane Laurent (S)

Department of Clinical Pharmacology and INSERM U 970, team 7, Paris CV Research Center (PARCC), Hôpital Européen Georges Pompidou, France (S.L.).

Peter M Nilsson (PM)

Department for Clinical Sciences Medicine, University Hospital, Malmö, Sweden (P.M.N.).

Allan Linneberg (A)

From the Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, The Capital Region of Denmark, Copenhagen, Denmark (J.K.K.V.-N., A.L.).
Department of Clinical Medicine, Faculty of Health and Medical Sciences (A.L.), University of Copenhagen, Denmark.

Thomas S G Sehested (TSG)

Department of Cardiology, Bispebjerg and Frederiksberg University Hospital, Copenhagen, Denmark (T.S.G.S.).

Sara V Greve (SV)

Cardiovascular and Metabolic Preventive Clinic, Department of Endocrinology, Odense University Hospital, Denmark (S.V.G.).

Manan Pareek (M)

Department of Cardiology, North Zealand Hospital, Hilleroed, Denmark (M.P.).
Department of Internal Medicine, Yale New Haven Hospital, Yale University School of Medicine, New Haven, CT (M.P.).

Luigi Palmieri (L)

Department of Cardiovascular, Endocrine-metabolic Diseases and Aging, National Centre of Epidemiology Surveillance and Health Promotion, National Institute of Health, Rome, Italy (L.P., S.G., C.D.).

Simona Giampaoli (S)

Department of Cardiovascular, Endocrine-metabolic Diseases and Aging, National Centre of Epidemiology Surveillance and Health Promotion, National Institute of Health, Rome, Italy (L.P., S.G., C.D.).

Chiara Donfrancesco (C)

Department of Cardiovascular, Endocrine-metabolic Diseases and Aging, National Centre of Epidemiology Surveillance and Health Promotion, National Institute of Health, Rome, Italy (L.P., S.G., C.D.).

Frank Kee (F)

Centre for Public Health, The Queen's University of Belfast, Northern Ireland (F.K.).

Giuseppe Mancia (G)

University of Milano-Bicocca and Policlinico di Monza, Italy (G.M.).

Giancarlo Cesana (G)

Research Centre on Public Health, University of Milano Bicocca, Villa Serena, Monza, Italy (G.C.).

Giovanni Veronesi (G)

Research Centre in Epidemiology and Preventive Medicine (EPIMED), Department of Medicine and Surgery, University of Insubria, Italy (G.V.).

Kari Kuulasmaa (K)

Finnish Institute for Health and Welfare (THL), Helsinki, Finland (K.K., V.S., J.K., T.P.).

Veikko Salomaa (V)

Finnish Institute for Health and Welfare (THL), Helsinki, Finland (K.K., V.S., J.K., T.P.).

Jukka Kontto (J)

Finnish Institute for Health and Welfare (THL), Helsinki, Finland (K.K., V.S., J.K., T.P.).

Tarja Palosaari (T)

Finnish Institute for Health and Welfare (THL), Helsinki, Finland (K.K., V.S., J.K., T.P.).

Susana Sans (S)

Catalan Department of Health, Barcelona, Spain (S. Sans).

Jean Ferrieres (J)

Department of Cardiology, Toulouse University School of Medicine, Rangueil Hospital, Toulouse Cedex 9, France (J.F.).

Jean Dallongeville (J)

Institut Pasteur de Lille, Lille Cedex, France (J.D.).

Stefan Söderberg (S)

Department of Public Health and Clinical Medicine, Cardiology and Heart Centre, Umeå University, Sweden (S. Söderberg).

Marie Moitry (M)

Department of Epidemiology and Public Health, University of Strasbourg, University Hospital of Strasbourg, France (M.M.).

Wojciech Drygas (W)

Department of Epidemiology, CVD Prevention and Health Promotion, National Institute of Cardiology, Warsaw, Poland (W.D.).

Abdonas Tamosiunas (A)

Lithuanian University of Health Sciences, Institute of Cardiology, Kaunas (A.T.).

Annette Peters (A)

German Research Center for Environmental Health, Institute of Epidemiology II, Neuherberg, Germany (A.P.).

Hermann Brenner (H)

German Cancer Research Center, Heidelberg, Germany; Network Aging Research, University of Heidelberg, Germany (H.B.).

Inger Njolstad (I)

Institute of Community Medicine, University of Tromsø, Norway (I.N.).

Michael H Olsen (MH)

Department of Internal Medicine, Holbaek Hospital, Denmark (M.H.O.).
Centre of Individualized Medicine in Arterial Diseases (CIMA), Department of Regional Health Research, University of Southern Denmark (M.H.O.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH